Phase III Daclatasvir and Sofosbuvir for Genotype 3 Chronic HCV

NCT02032901 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

173

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis C

Interventions

DRUG: Daclatasvir
DRUG: Sofosbuvir

Sponsor

Bristol-Myers Squibb